首页> 外文OA文献 >CHI3L1 Is a Liver-Enriched, Noninvasive Biomarker That Can Be Used to Stage and Diagnose Substantial Hepatic Fibrosis

【2h】

CHI3L1 Is a Liver-Enriched, Noninvasive Biomarker That Can Be Used to Stage and Diagnose Substantial Hepatic Fibrosis

机译：CHI3L1是一种富含肝富集的非侵入性生物标志物，可用于阶段和诊断大量肝纤维化

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Haijun Huang; Tiangang Wu; Jian Mao; Yongxing Fang; Jiajie Zhang; Lihua Wu; Shu Zheng; Biaoyang Lin; Hongying Pan;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Noninvasive hepatic fibrosis scores developed in adults had poor performance in diagnosing fibrosis in Chinese children with NASH [J] . Zhang Min, Chen Dawei, Dong Yi, Hepatology: Official Journal of the American Association for the Study of Liver Diseases . 2017,第Suppla1期

机译：在成人中发育的非侵入性肝纤维化分数在纳什诊断中国儿童纤维化方面具有差的表现差
2. The impact of liver disease aetiology and the stages of hepatic fibrosis on the performance of non-invasive fibrosis biomarkers: an international study of 2411 cases. [J] . Sebastiani G, Castera L, Halfon P, Alimentary pharmacology & therapeutics. . 2011,第10期

机译：肝病病因学和肝纤维化分期对无创性纤维化生物标志物性能的影响：2411例国际研究。
3. The impact of liver disease aetiology and the stages of hepatic fibrosis on the performance of non-invasive fibrosis biomarkers: an international study of 2411 cases [J] . G. Sebastiani, L. Castera, P. Halfon, Alimentary Pharmacology & Therapeutics . 2011,第10期

机译：肝病病因学和肝纤维化分期对无创性纤维化生物标志物性能的影响：2411例国际研究
4. Multiparametric study to identify the hepatic fibrosis stages [C] . Meziri M., Bouzitoune R., Machado C.B., Ultrasonics Symposium (IUS), 2009 . 2009

机译：多参数研究以鉴定肝纤维化分期
5. Noninvasive Assessment of Neurochemical Biomarkers in Humans with Amyotrophic Lateral Sclerosis: Correlates of Clinical Heterogeneity [D] . Cheong, Ian 2018

机译：肌萎缩性侧索硬化症患者神经化学生物标记物的非侵入性评估：临床异质性的相关性。
6. CHI3L1 Is a Liver-Enriched Noninvasive Biomarker That Can Be Used to Stage and Diagnose Substantial Hepatic Fibrosis [O] . Haijun Huang, Tiangang Wu, Jian Mao, -1

机译：CHI3L1是富含肝脏的非侵入性生物标志物可用于分期和诊断实质性肝纤维化
7. The impact of liver disease aetiology and the stages of hepatic fibrosis on the performance of non-invasive fibrosis biomarkers: an international study of 2411 cases [O] . Sebastiani G, Castera L, Halfon P, 2011

机译：肝病病因学和肝纤维化分期对非侵入性纤维化生物标志物性能的影响：2411例国际研究
8. Development of Noninvasive Biomarkers for Diagnosing and Monitoring Nonindolent Prostate Cancer. [R] . D. Bianchi-Frias 2013

机译：用于诊断和监测非耐受性前列腺癌的无创生物标志物的开发。

CHI3L1 Is a Liver-Enriched, Noninvasive Biomarker That Can Be Used to Stage and Diagnose Substantial Hepatic Fibrosis

著录项

引文网络

相似文献

相关主题

期刊订阅